Showing results (2031-2040 of 7,742) with videos related to

Sort By:
Pageof 775
Critical Reviews in Immunology|December 14, 2004
Interleukin 21: a key player in lymphocyte maturationStephen L Nutt, Jason Brady, Yoshihiro Hayakawa, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
Evidence-based treatment of haemophiliaP H B Bolton-Maggs, K Stobart, R L Smyth
Journal of Pharmaceutical Sciences|July 7, 2011
Moisture content impacts the stability of DNA adsorbed onto gold microparticlesTyson J Smyth, Jamie Betker, Wei Wang, et al.
Advances in Immunology|March 1, 2016
Mouse Models of Tumor ImmunotherapyShin Foong Ngiow, Sherene Loi, David Thomas, et al.
International Journal of Pharmaceutics|May 19, 2019
A human skin high-throughput formulation screening method using a model hydrophilic drugPatricia P Martins, Arnold D Estrada, Hugh D C Smyth
Antioxidants (Basel, Switzerland)|April 23, 2022
Hypothiocyanous Acid Disrupts the Barrier Function of Brain Endothelial CellsEveline van Leeuwen, Mark B Hampton, Leon C D Smyth
Foods (Basel, Switzerland)|March 10, 2022
Predicting Satiety from the Analysis of Human Saliva Using Mid-Infrared Spectroscopy Combined with ChemometricsDongdong Ni, Heather E Smyth, Michael J Gidley, et al.
JAMA|April 20, 1999
Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trialJ M Smyth, A A Stone, A Hurewitz, et al.
Anti-Cancer Drug Design|October 1, 1995
Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugsI Meikle, J Cummings, J S Macpherson, et al.
Journal of Chromatography. B, Biomedical Applications|October 11, 1996
Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatographyJ Cummings, I Meikle, J S Macpherson, et al.
Pageof 775